Auf dieser Seite
RNAC Cartesian Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$7,36
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$5,6052-Wochen-Tief
$11,0052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$221M
P/E (TTM)
-1.3
EPS (TTM)
$-5.84
Umsatz (TTM)
$1M
Ihre Abzeichen
52W-Spanne
$6–$11
Analystenbewertung
BUY
Kursziel
$34
P/E
-1.3
ROE
237.8%
Nettogewinnmarge
-10283.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
RNAC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$7.36
Marktkapitalisierung (MRQ)
$221M
P/E (TTM)
-1.3
EPS (TTM)
$-5.84
Umsatz (TTM)
$1M
ROE (TTM)
237.8%
Verschuldungsgrad (MRQ)
-0.4
52W-Spanne
$6–$11
RNAC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 5. April 2024 | 1-for-30 | Umgekehrt |
Über Cartesian Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter75
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$3M2017-12-31 → 2025-12-31
EPS$-5.022019-12-31 → 2025-12-31
Freier Cashflow$-79M2017-12-31 → 2025-12-31
Nettogewinnmarge-10283.8%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | RNAC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.35-Jahres-Durchschnitt ≈-22.3 | ≈-22.3 | · | · | |
| P/S (TTM) | 149.75-Jahres-Durchschnitt ≈63.6 | ≈63.6 | 36.6 | Überbewertet | |
| K/B (MRQ) | -1.85-Jahres-Durchschnitt ≈-5.4 | ≈-5.4 | · | · | |
| Kurs / FCF (TTM) | -2.85-Jahres-Durchschnitt ≈-59.9 | ≈-59.9 | · | · | |
| Kurs / Cashflow (TTM) | -2.95-Jahres-Durchschnitt ≈-62.9 | ≈-62.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | RNAC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -10518.6%5-Jahres-Durchschnitt ≈-1389.8% | ≈-1389.8% | -734.7% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -5127.1%5-Jahres-Durchschnitt ≈-1389.8% | ≈-1389.8% | -734.7% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -4987.3%5-Jahres-Durchschnitt ≈-1518.0% | ≈-1518.0% | -1318.8% | Schwach | |
| Nettogewinnmarge (TTM) | -10283.8%5-Jahres-Durchschnitt ≈-1417.6% | ≈-1417.6% | -1287.2% | Schwach | |
| ROA (TTM) | -42.9%5-Jahres-Durchschnitt ≈-32.0% | ≈-32.0% | -30.8% | Schwach | |
| ROE (TTM) | 237.8%5-Jahres-Durchschnitt ≈729.3% | ≈729.3% | -23.4% | Spitzenklasse | |
| ROIC | 106.1%5-Jahres-Durchschnitt ≈196.9% | ≈196.9% | 8.4% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | RNAC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | -0.4 | · | · | · | |
| Liquiditätsgrad (MRQ) | 7.55-Jahres-Durchschnitt ≈6.3 | ≈6.3 | 7.7 | Im Einklang | |
| Quick Ratio | 8.55-Jahres-Durchschnitt ≈5.9 | ≈5.9 | 6.5 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | -0.4 | · | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | RNAC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -92.8%5-Jahres-Durchschnitt ≈64.6% | ≈64.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -70.7%5-Jahres-Durchschnitt ≈-25.8% | ≈-25.8% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -30.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | RNAC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.0 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 2.85-Jahres-Durchschnitt ≈8.0 | ≈8.0 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$37.3K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-16.2%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $0.61 | $-0.89 | 168.9% |
| 31. März 2026 | Mai 7, 2026 | $-1.46 | $-0.90 | -62.0% |
| 31. Dezember 2025 | $-3.57 | $-0.87 | -310.2% | |
| 30. September 2025 | $-1.38 | $-0.86 | -60.1% | |
| 30. Juni 2025 | $0.50 | $-0.83 | 160.5% | |
| 31. März 2025 | $-0.68 | $-0.72 | 5.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $39M | $26M | $111M | $85M | $17M | $7M | $903.0K | · | $8M | $6M | |
| R&D Expense | $58M | $45M | $71M | $72M | $69M | $55M | $43M | $48M | · | $30M | $23M | |
| SG&A Expense | $31M | $30M | $40M | $24M | $21M | $19M | $16M | $18M | · | $13M | $8M | |
| Operating Expenses | $146M | $83M | $112M | $96M | $90M | $73M | $59M | $66M | · | $43M | $31M | |
| Operating Income | $-143M | $-44M | $-86M | $15M | $-5M | $-57M | $-52M | $-65M | · | $-35M | $-25M | |
| Interest Expense | · | · | $3M | $3M | $3M | $2M | $2M | $1M | · | $1M | $948.0K | |
| Interest Income | $7M | $7M | $5M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-2M | $606.0K | $691.0K | $330.0K | $15.0K | $89.0K | $-1M | $10.0K | · | $4.0K | $-26.0K | |
| Pretax Income | $-139M | $-77M | $-239M | $35M | $-10M | $-69M | $-55M | · | · | · | · | |
| Income Tax | $-9M | $287.0K | $-19M | $-609.0K | $16M | $0 | $0 | · | · | · | · | |
| Net Income | $-130M | $-77M | $-220M | $35M | $-26M | $-69M | $-55M | $-65M | · | $-36M | $-25M | |
| EPS (Basic) | $-5.02 | $-4.48 | $-49.76 | $0.24 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · | |
| EPS (Diluted) | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · | |
| Shares (Basic) | 25,973,329 | 17,276,822 | 5,170,319 | 144,758,555 | 114,328,798 | 101,202,176 | 45,548,511 | · | · | · | · | |
| Shares (Diluted) | 25,973,329 | 17,357,943 | 5,170,319 | 145,874,889 | 114,328,798 | 101,202,176 | 45,548,511 | · | · | · | · | |
| EBITDA | $-143M | $-44M | $-86M | $15M | · | $-57M | $-52M | $-65M | · | $-35M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $213M | $77M | $106M | $114M | $139M | $90M | $37M | · | $59M | $32M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $26M | $25M | $4M | |
| Receivables | $1M | $872.0K | $6M | $7M | $10M | $7M | $5M | $0 | $63.0K | $215.0K | $824.0K | |
| Prepaid Expense | $3M | $3M | $5M | $4M | $6M | $5M | $1M | $5M | $2M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | $80.0K | · | · | · | |
| Current Assets | $129M | $217M | $91M | $148M | $144M | $151M | $97M | $42M | $99M | $87M | $39M | |
| PP&E (Net) | $12M | $10M | $2M | $3M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $17M | $12M | $8M | $8M | $7M | $6M | $6M | $7M | · | $6M | $5M | |
| Accum. Depreciation | $5M | $2M | $6M | $5M | $5M | $4M | $5M | $5M | · | $4M | $3M | |
| Goodwill | $48M | $48M | $48M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | $518.0K | $0 | · | · | · | · | · | · | $122.0K | $2M | |
| Total Assets | $296M | $435M | $305M | $166M | $160M | $165M | $100M | $44M | $101M | $89M | $43M | |
| Accounts Payable | $1M | $288.0K | $3M | $316.0K | $224.0K | $443.0K | $500.0K | $1M | $2M | $4M | $2M | |
| Accrued Liabilities | $9M | $12M | $15M | $14M | $11M | $8M | $13M | $12M | $9M | $4M | $3M | |
| Current Liabilities | $15M | $23M | $68M | $25M | $72M | $82M | $35M | $35M | $11M | $14M | $7M | |
| Capital Leases | $9M | $11M | $9M | $10M | $9M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $7M | $16M | $16M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $938.0K | $1M | $0 | $290.0K | |
| Total Liabilities | $423M | $442M | $445M | $72M | $137M | $183M | $91M | $50M | $47M | $34M | $22M | |
| Common Stock | $3.0K | $3.0K | $1.0K | $15.0K | $12.0K | $11.0K | $9.0K | $3.0K | $3.0K | $1.0K | $0 | |
| Paid-in Capital | $701M | $690M | $179M | $493M | $457M | $391M | $349M | $280M | $273M | $211M | $1.0K | |
| Retained Earnings | $-822M | $-692M | $-615M | $-395M | $-430M | $-405M | $-336M | $-280M | $-215M | $-152M | $-112M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-4M | $-5M | $-5M | |
| Stockholders' Equity | $-126M | $-7M | $-440M | $94M | $23M | $-18M | $8M | $-5M | $54M | $55M | $-116M | |
| Liabilities + Equity | $296M | $435M | $305M | $166M | $160M | $165M | $100M | $44M | $101M | $89M | $43M | |
| Shares Outstanding | 26,011,106 | 25,767,369 | 5,397,597 | 5,101,459 | 123,622,965 | 108,071,249 | 86,325,547 | 22,471,776 | · | 18,438,742 | 2,173,399 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $23M | $11M | $8M | $5M | $5M | $6M | · | · | · | |
| Deferred Tax | $-9M | $287.0K | $-19M | $0 | $0 | · | · | $0 | · | · | · | |
| Restructuring | $0 | $798.0K | $6M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-74M | $-24M | $-51M | $-32M | $-60M | $35M | $-51M | $-59M | · | $-20M | $-22M | |
| CapEx | $5M | $9M | $206.0K | $1M | $1M | $815.0K | $47.0K | $884.0K | · | $586.0K | $1M | |
| Investing Cash Flow | $-5M | $-9M | $35M | $-15M | $-17M | $-741.0K | $229.0K | $25M | · | $-22M | $-5M | |
| Debt Issued | · | · | · | $0 | $0 | $25M | $0 | $0 | · | · | · | |
| Net Debt Issued | · | $0 | $-27M | $0 | · | $5M | $-3M | $0 | · | $0 | · | |
| Stock Issued | · | · | · | $2M | $52M | $2M | $31M | $0 | · | $3M | $0 | |
| Net Stock Activity | · | · | · | $2M | · | · | $31M | $0 | · | $3M | · | |
| Financing Cash Flow | $-8M | $168M | $-13M | $39M | $53M | $14M | $105M | $697.0K | · | $68M | $44M | |
| Net Change in Cash | $-87M | $136M | $-30M | $-7M | $-25M | $49M | $54M | $-33M | · | $26M | $16M | |
| Free Cash Flow | $-79M | $-33M | $-51M | $-33M | · | $34M | $-51M | $-60M | · | $-20M | · | |
| Levered FCF | · | · | $-54M | $-36M | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5127.1% | -112.8% | -332.3% | 13.1% | · | -342.4% | -785.6% | -7200.7% | · | -428.9% | · | |
| Net Margin | -4658.6% | -199.0% | -844.9% | 31.9% | · | -415.0% | -829.0% | -7235.4% | · | -448.0% | · | |
| Pretax Margin | -4987.3% | -198.2% | -918.0% | 31.4% | · | · | · | · | · | · | · | |
| EBITDA Margin | -5127.1% | -112.8% | -332.3% | 13.1% | · | -342.4% | -785.6% | -7200.7% | · | -428.9% | · | |
| ROA | -35.6% | -20.9% | -93.3% | 21.7% | · | -52.0% | -76.8% | · | · | -54.8% | · | |
| ROE | 202.4% | 2559.5% | 115.7% | 39.6% | · | 542.6% | -3179.2% | · | · | 117.7% | · | |
| ROIC | 106.1% | 647.8% | 18.1% | 15.8% | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.7 | 9.4 | 1.3 | 5.9 | · | 1.9 | 2.8 | · | · | 6.3 | · | |
| Quick Ratio | 8.5 | 9.3 | 1.2 | 4.5 | · | 1.8 | 2.7 | · | · | 6.2 | · | |
| Interest Coverage | · | · | -30.5 | 4.8 | · | -36.5 | -34.5 | -43.5 | · | -27.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.7 | · | 0.1 | 0.1 | · | · | 0.1 | · | |
| Receivables Turnover | 2.8 | 11.5 | 4.2 | 13.4 | · | 2.7 | 2.7 | · | · | 15.6 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.85 | $-0.26 | $-2.72 | $0.61 | · | $-0.17 | $0.10 | · | · | $2.98 | · | |
| Revenue / Share | $0.11 | $2.24 | $0.17 | $0.76 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.85 | $-1.36 | $-0.33 | $-0.22 | · | · | · | · | · | · | · | |
| Cash / Share | $4.81 | $8.25 | $0.47 | $0.70 | · | $1.28 | $1.04 | · | · | $3.18 | · | |
| EPS (TTM) | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -92.8% | 49.6% | -76.5% | 30.2% | 412.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -70.7% | -22.9% | 16.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -30.0% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $39M | $26M | $111M | $85M | $17M | $7M | $903.0K | · | $8M | · | |
| Net Income TTM | $-130M | $-77M | $-220M | $35M | $-26M | $-69M | $-55M | $-65M | · | $-36M | · | |
| Market Cap | $188M | $461M | $3.35B | $5.19B | · | $9.82B | $6.16B | · | · | $9.49B | · | |
| P/E | -1.4 | -4.0 | -0.4 | 339.0 | -444.5 | -133.7 | -58.5 | · | · | · | · | |
| P/S | 67.1 | 11.9 | 128.7 | 46.8 | · | 591.9 | 923.1 | · | · | 1173.7 | · | |
| P/B | -1.5 | -67.8 | -7.6 | 55.3 | · | -545.6 | 734.0 | · | · | 172.6 | · | |
| P / Tangible Book | · | · | · | 55.3 | 536.8 | · | · | · | · | · | · | |
| P / Cash Flow | -2.5 | -19.5 | -65.4 | -164.0 | · | 281.6 | -119.8 | · | · | -482.0 | · | |
| P / FCF | -2.4 | -14.1 | -65.2 | -158.0 | · | 288.4 | -119.7 | · | · | -468.0 | · | |
| Earnings Yield | -69.6% | -25.1% | -240.7% | 0.29% | -0.22% | -0.75% | -1.7% | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $78.0K | $947.0K | $452.0K | $298.0K | $1M | $-759.0K | $387.0K | $33M | $6M | $8M | $7M | $5M | $6M | $17M | $21M | |
| R&D Expense | $20M | $19M | $15M | $14M | $15M | $15M | $11M | $11M | $13M | $10M | $22M | $13M | $18M | $19M | $19M | $17M | |
| SG&A Expense | $9M | $7M | $8M | $8M | $7M | $8M | $7M | $7M | $7M | $9M | $22M | $7M | $6M | $6M | $6M | $6M | |
| Operating Expenses | $29M | $27M | $80M | $22M | $22M | $23M | $26M | $18M | $20M | $19M | $45M | $20M | $24M | $24M | $25M | $22M | |
| Operating Income | $-29M | $-26M | $-79M | $-21M | $-22M | $-22M | $-27M | $-18M | $14M | $-13M | $-36M | $-13M | $-19M | $-18M | $-8M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | $1M | $752.0K | $808.0K | $807.0K | $802.0K | |
| Interest Income | $1M | $1M | · | · | $2M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $126.0K | $-3.0K | $-2M | $0 | $-5.0K | $0 | $-444.0K | $250.0K | $292.0K | $508.0K | $-62.0K | $253.0K | $245.0K | $255.0K | $175.0K | $1.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-197M | $-9M | · | · | $6M | $-8M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-288.0K | $-321.0K | |
| Net Income | $16M | $-39M | $-93M | $-36M | $16M | $-18M | $-10M | $-24M | $14M | $-57M | $-178M | $-9M | $-11M | $-22M | $6M | $-8M | |
| EPS (Basic) | $0.47 | $-1.46 | $-3.47 | $-1.38 | $0.51 | $-0.68 | $6.57 | $-1.13 | $0.58 | $-10.50 | $-41.55 | $-1.74 | $-2.23 | $-4.24 | $0.00 | $-0.05 | |
| EPS (Diluted) | $0.46 | $-1.46 | $-3.46 | $-1.38 | $0.50 | $-0.68 | $6.60 | $-1.13 | $0.54 | $-10.50 | $-41.55 | $-1.74 | $-2.23 | $-4.24 | $0.01 | $-0.05 | |
| Shares (Basic) | 29,467,130 | 26,855,158 | · | 26,002,892 | 25,980,262 | 25,902,650 | · | 21,471,408 | 16,723,479 | 5,414,020 | · | 5,160,150 | 5,114,747 | 5,111,518 | · | 152,849,992 | |
| Shares (Diluted) | 29,860,880 | 26,855,158 | · | 26,002,892 | 26,447,251 | 25,902,650 | · | 21,471,408 | 17,791,143 | 5,414,020 | · | 5,160,150 | 5,114,747 | 5,111,518 | · | 152,849,992 | |
| EBITDA | $-29M | $-26M | · | $-21M | $-22M | $-22M | · | $-18M | $14M | $-13M | · | $-13M | $-19M | $-18M | · | $-2M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $148M | $119M | $125M | $143M | $160M | $180M | $213M | $219M | $87M | $103M | $77M | $80M | $112M | $126M | $106M | $113M | |
| Receivables | $196.0K | $261.0K | $1M | $722.0K | $354.0K | $2M | $872.0K | $5M | $32M | $2M | $6M | $5M | $5M | $7M | $7M | $7M | |
| Prepaid Expense | $6M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $2M | $3M | $5M | $3M | $4M | $4M | $4M | $6M | |
| Current Assets | $154M | $122M | $129M | $147M | $163M | $185M | $217M | $229M | $125M | $111M | $91M | $90M | $123M | $138M | $148M | $160M | |
| PP&E (Net) | $11M | $12M | $12M | $12M | $12M | $10M | $10M | $10M | $7M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $17M | $17M | $17M | $17M | $16M | $13M | $12M | $17M | $13M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Accum. Depreciation | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | |
| Goodwill | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | · | · | · | $0 | · | |
| Other Non-current Assets | · | · | · | · | $6M | $6M | · | · | · | · | $0 | · | · | · | · | · | |
| Total Assets | $319M | $288M | $296M | $373M | $389M | $409M | $435M | $455M | $348M | $325M | $305M | $106M | $140M | $156M | $166M | $178M | |
| Accounts Payable | $1M | $2M | $1M | $2M | $454.0K | $2M | $288.0K | $517.0K | $3M | $3M | $3M | $375.0K | $267.0K | $1M | $316.0K | $214.0K | |
| Accrued Liabilities | $15M | $10M | $9M | $8M | $8M | $9M | $12M | $9M | $11M | $9M | $15M | $14M | $13M | $9M | $14M | $12M | |
| Current Liabilities | $21M | $16M | $15M | $14M | $12M | $15M | $23M | $21M | $26M | $37M | $68M | $20M | $29M | $27M | $25M | $24M | |
| Capital Leases | $7M | $8M | $9M | $9M | $10M | $10M | $11M | $12M | $12M | $8M | $9M | $9M | $9M | $10M | $10M | $11M | |
| Deferred Tax | $7M | $7M | $7M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | · | · | · | $0 | · | |
| Total Liabilities | $444M | $437M | $423M | $409M | $391M | $431M | $442M | $455M | $449M | $442M | $445M | $46M | $74M | $81M | $72M | $93M | |
| Total Debt | $53M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $1.0K | $1.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | |
| Paid-in Capital | $725M | $718M | $701M | $699M | $696M | $693M | $690M | $687M | $561M | $559M | $179M | $502M | $498M | $496M | $493M | $490M | |
| Retained Earnings | $-846M | $-862M | $-822M | $-730M | $-694M | $-710M | $-692M | $-682M | $-658M | $-671M | $-615M | $-437M | $-428M | $-417M | $-395M | $-401M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Stockholders' Equity | $-125M | $-148M | $-126M | $-36M | $-3M | $-22M | $-7M | $752.0K | $-101M | $-117M | $-440M | $60M | $65M | $75M | $94M | $85M | |
| Liabilities + Equity | $319M | $288M | $296M | $373M | $389M | $409M | $435M | $455M | $348M | $325M | $305M | $106M | $140M | $156M | $166M | $178M | |
| Shares Outstanding | 30,037,962 | 28,544,728 | 26,011,106 | 26,003,606 | 26,000,065 | 25,936,101 | 25,767,369 | 23,896,525 | 17,816,238 | 5,515,836 | 5,397,597 | 154,854,032 | 153,427,571 | 153,426,983 | 153,042,435 | 153,028,822 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $14M | $2M | $4M | $2M | $2M | $3M | |
| Restructuring | · | · | $0 | $0 | $0 | $0 | $21.0K | $-23.0K | $505.0K | $292.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-22M | $-18M | $-16M | $-18M | $-23M | $-7M | $14M | $-14M | $-16M | $-23M | $-9M | $-10M | $-9M | $-12M | $4M | |
| CapEx | $272.0K | $27.0K | $492.0K | $1M | $3M | $1M | $705.0K | $6M | $2M | $602.0K | $64.0K | $0 | $12.0K | $130.0K | $211.0K | $436.0K | |
| Investing Cash Flow | $-272.0K | $-27.0K | $-492.0K | $-1M | $-3M | $-1M | $-354.0K | $-6M | $-2M | $-602.0K | $6M | $0 | $-12.0K | $28M | $5M | $-30M | |
| Stock Issued | $4M | $15M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $50M | $16M | $-52.0K | $-38.0K | $60.0K | $-8M | $783.0K | $124M | $120.0K | $43M | $14M | $-25M | $-3M | $149.0K | $0 | $612.0K | |
| Net Change in Cash | $29M | $-6M | $-18M | $-17M | $-20M | $-32M | $-7M | $132M | $-16M | $27M | $-3M | $-34M | $-13M | $19M | $-6M | $-25M | |
| Free Cash Flow | · | $-22M | · | · | · | $-24M | · | · | · | $-17M | · | · | · | $-9M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -33973.1% | · | -4660.6% | -7319.1% | -1989.9% | · | -4541.3% | 41.1% | -228.6% | · | -199.4% | -355.1% | -309.6% | · | -7.7% | |
| Net Margin | · | -50233.3% | · | -7942.9% | 5330.9% | -1610.0% | · | -6248.8% | 41.4% | -973.0% | · | -137.4% | -216.9% | -364.8% | · | -38.1% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -137.4% | · | · | · | -39.7% | |
| EBITDA Margin | · | -33973.1% | · | -4660.6% | -7319.1% | -1989.9% | · | -4541.3% | 41.1% | -228.6% | · | -199.4% | -355.1% | -309.6% | · | -7.7% | |
| ROA | 4.5% | -11.2% | · | -8.7% | 4.3% | -4.8% | · | -8.6% | 5.7% | -23.6% | · | -6.3% | -7.0% | -14.4% | · | -4.6% | |
| ROE | -24.7% | 46.1% | · | 204.6% | -30.6% | 25.6% | · | -79.2% | -76.8% | 269.2% | · | -12.4% | -14.7% | -33.2% | · | -23.8% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.5 | 7.7 | · | 10.7 | 13.3 | 12.3 | · | 10.7 | 4.8 | 3.0 | · | 4.5 | 4.2 | 5.2 | · | 6.7 | |
| Quick Ratio | 7.2 | 7.5 | · | 10.4 | 13.1 | 12.1 | · | 10.5 | 4.6 | 2.9 | · | 4.2 | 4.0 | 5.0 | · | 5.0 | |
| Debt / Equity | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -10.3 | -24.8 | -22.7 | · | -2.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 0.0 | 0.1 | · | 0.2 | 0.0 | 0.6 | · | 0.1 | 1.8 | 1.3 | · | 1.1 | 0.4 | 0.8 | · | 2.9 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.17 | $-5.19 | · | $-1.38 | $-0.10 | $-0.84 | · | $0.03 | $-5.69 | $-21.18 | · | $0.39 | $0.43 | $0.49 | · | $0.55 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.02 | $0.01 | $0.04 | · | $0.02 | $1.88 | $1.08 | · | $0.04 | $0.03 | $0.04 | · | $0.14 | |
| Cash Flow / Share | · | $-0.82 | · | · | · | $-0.89 | · | · | · | $-2.94 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $4.91 | $4.16 | · | $5.51 | $6.17 | $6.96 | · | $9.17 | $4.90 | $18.75 | · | $0.51 | $0.73 | $0.82 | · | $0.74 | |
| EPS (TTM) | $-5.84 | $-5.80 | · | $5.04 | $5.29 | $5.33 | · | $-52.64 | $-53.25 | $-56.02 | · | $-8.20 | $-6.51 | $-4.22 | · | $0.25 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | · | $1M | $1M | $34M | · | $48M | $54M | $26M | · | $35M | $49M | $83M | · | $124M | |
| Net Income TTM | $-152M | $-152M | · | $-48M | $-36M | $-38M | · | $-245M | $-230M | $-255M | · | $-36M | $-35M | $-15M | · | $42M | |
| Market Cap | $313M | $176M | · | $266M | $270M | $342M | · | $385M | $481M | $108M | · | $4.92B | $5.16B | $6.40B | · | $7.53B | |
| Enterprise Value | $218M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.8 | -1.1 | · | 2.0 | 2.0 | 2.5 | · | -0.3 | -0.5 | -0.3 | · | -3.9 | -5.2 | -9.9 | · | 196.8 | |
| P/S | 211.9 | 98.9 | · | 243.6 | 263.3 | 10.0 | · | 8.0 | 8.9 | 4.2 | · | 142.6 | 105.9 | 77.3 | · | 60.8 | |
| P/B | -2.5 | -1.2 | · | -7.4 | -106.9 | -15.7 | · | 512.2 | -4.7 | -0.9 | · | 81.6 | 78.8 | 85.8 | · | 88.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 81.6 | 78.8 | 85.8 | · | 88.7 | |
| P / Cash Flow | · | -7.9 | · | · | · | -14.8 | · | · | · | -6.8 | · | · | · | -729.9 | · | · | |
| EV / Revenue | 147.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -56.0% | -94.3% | · | 49.3% | 50.9% | 40.4% | · | -326.6% | -197.2% | -287.3% | · | -25.8% | -19.4% | -10.1% | · | 0.51% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $3M | $39M | $26M | $111M | $85M |
| Betriebsgewinnmarge % | -5127.1% | -112.8% | -332.3% | 13.1% | · |
| Nettoergebnis | $-130M | $-77M | $-220M | $35M | $-26M |
| Verwässerte EPS | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 8.7 | 9.4 | 1.3 | 5.9 | · |
| Quick Ratio | 8.5 | 9.3 | 1.2 | 4.5 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-79M | $-33M | $-51M | $-33M | · |
Institutionelle Eigentümer (13F) 101 Einreicher · $93.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
101
Gehaltener Wert
$93.7M
Neue Positionen
27
Geschlossene Positionen
11
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 27 (-1 vs. Vorquartal) | 11 (-1 vs. Vorquartal) | 44 (+16 vs. Vorquartal) | 12 (-2 vs. Vorquartal) | +1.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Squarepoint Ops LLC | $23.493.130 | 2.254.619 | 25,08% | Aktien |
| BlackRock, Inc. | $8.536.469 | 819.239 | 9,11% | Aktien |
| 683 Capital Management, LLC | $6.773.001 | 650.000 | 7,23% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.791.676 | 555.823 | 6,18% | Aktien |
| VANGUARD GROUP INC | $3.902.253 | 541.228 | 4,17% | Aktien |
| FMR LLC | $3.839.030 | 368.429 | 4,10% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.715.412 | 356.525 | 3,97% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $3.714.267 | 356.456 | 3,96% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.229.023 | 309.887 | 3,45% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $3.087.373 | 296.293 | 3,30% | Aktien |
| STATE STREET CORP | $2.596.789 | 249.212 | 2,77% | Aktien |
| MARSHALL WACE, LLP | $2.427.018 | 232.919 | 2,59% | Aktien |
| UBS Group AG | $2.174.102 | 208.647 | 2,32% | Aktien |
| Privium Fund Management B.V. | $1.580.454 | 151.675 | 1,69% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.351.474 | 129.700 | 1,44% | Kaufoption |
| NORTHERN TRUST CORP | $1.101.373 | 105.698 | 1,18% | Aktien |
| ADAR1 Capital Management, LLC | $1.030.298 | 98.877 | 1,10% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $957.119 | 91.854 | 1,02% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $909.843 | 87.317 | 0,97% | Aktien |
| DIADEMA PARTNERS LP | $907.134 | 87.057 | 0,97% | Aktien |
| BANK OF AMERICA CORP /DE/ | $881.782 | 84.624 | 0,94% | Aktien |
| Walleye Capital LLC | $852.648 | 81.828 | 0,91% | Aktien |
| GOLDMAN SACHS GROUP INC | $839.560 | 80.572 | 0,90% | Aktien |
| Jump Financial, LLC | $696.056 | 66.800 | 0,74% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $666.640 | 63.977 | 0,71% | Aktien |
| Nuveen, LLC | $661.191 | 63.454 | 0,71% | Aktien |
| CM Management, LLC | $625.200 | 60.000 | 0,67% | Aktien |
| Point72 Asset Management, L.P. | $454.590 | 43.627 | 0,49% | Aktien |
| Trexquant Investment LP | $427.699 | 41.046 | 0,46% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $338.650 | 32.500 | 0,36% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $335.191 | 32.168 | 0,36% | Aktien |
| Bank of New York Mellon Corp | $331.523 | 31.816 | 0,35% | Aktien |
| D. E. Shaw & Co., Inc. | $298.543 | 28.651 | 0,32% | Aktien |
| Atlatl Advisers LLC | $297.064 | 28.509 | 0,32% | Aktien |
| IEQ CAPITAL, LLC | $264.835 | 25.416 | 0,28% | Aktien |
| TWIN FOCUS CAPITAL PARTNERS, LLC | $260.500 | 25.000 | 0,28% | Aktien |
| Persistent Asset Partners Ltd | $231.230 | 22.191 | 0,25% | Aktien |
| Miller Financial Services LLC | $230.730 | 22.143 | 0,25% | Aktien |
| Erste Asset Management GmbH | $227.176 | 23.566 | 0,24% | Aktien |
| Ikarian Capital, LLC | $216.809 | 20.807 | 0,23% | Aktien |
| Invesco Ltd. | $215.559 | 20.687 | 0,23% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $212.568 | 20.400 | 0,23% | Verkaufsoption |
| RENAISSANCE TECHNOLOGIES LLC | $211.526 | 20.300 | 0,23% | Aktien |
| XTX Topco Ltd | $202.096 | 19.395 | 0,22% | Aktien |
| Brevan Howard Capital Management LP | $201.783 | 19.365 | 0,22% | Aktien |
| TWO SIGMA ADVISERS, LP | $178.866 | 24.808 | 0,19% | Aktien |
| Cerity Partners LLC | $175.557 | 16.848 | 0,19% | Aktien |
| Mariner, LLC | $154.334 | 14.813 | 0,16% | Aktien |
| JANE STREET GROUP, LLC | $141.712 | 13.600 | 0,15% | Kaufoption |
| RHUMBLINE ADVISERS | $140.589 | 13.493 | 0,15% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Murat Kalayoglu, Seven One Eight Three Four Irrevocable Trust, Elizabeth Hoge, Sinan Kalayoglu ×4 Einreichungen | 2. April 2026 | 19,90% | Änderung | · | SEC |
| Timothy A. Springer, TAS Partners LLC, Chafen Lu ×20 Einreichungen | 15. Januar 2025 | 36,90% | Änderung | · | SEC |
| Michael Singer, Thirsty Brook 2010 Irrevocable Trust, Singer Asefzadeh Family Holding Trust, Bakezilla 2019 Irrevocable Trust, Baharak Asefzadeh, Barbara P. Martin ×2 Einreichungen | 10. April 2024 | · | Erste Einreichung | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire, Amir Nashat ×5 Einreichungen | 12. Februar 2020 | · | Erste Einreichung | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×6 Einreichungen | 5. Februar 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 39 Insider · 21 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Carsten Brunn | President and CEO | 6. Januar 2026 S | 323.530 | 0 | 1 | $-162.084 |
| Werner Cautreels | President and CEO | 13. November 2017 P | 321.203 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 6. Januar 2026 S | 121.220 | 0 | 1 | $-72.231 |
| Kevin Tan | Chief Financial Officer | 3. Januar 2022 A | 77.000 | 0 | 0 | $0 |
| Bradford D. Dahms | Chief Financial Officer | 4. Januar 2021 A | 38.000 | 0 | 0 | $0 |
| John Harold Leaman | CFO, Treas. & Hd Corp Strategy | 15. Juni 2018 A | · | 0 | 0 | $0 |
| David Siewers | CFO and Treasurer | 20. September 2017 M | 0 | 0 | 0 | $0 |
| Milos Miljkovic | Chief Medical Officer | 6. Januar 2026 S | 58.820 | 0 | 1 | $-24.368 |
| June Ann Seymour | Chief Accounting Officer | 2. Januar 2026 A | 6.500 | 0 | 0 | $0 |
| Emily English | Chief Operations Officer | 2. Januar 2026 A | 94.226 | 0 | 0 | $0 |
| Christopher M Jewell | Chief Scientific Officer | 10. Januar 2025 M | 62.490 | 0 | 0 | $0 |
| Metin Kurtoglu | Chief Technology Officer | 6. Januar 2025 S | 62.258 | 0 | 0 | $0 |
| Peter G Traber | Chief Medical Officer | 25. September 2023 S | 451.826 | 0 | 0 | $0 |
| Takashi Kei Kishimoto | Chief Scientific Officer | 31. Mai 2023 G | 225.316 | 0 | 0 | $0 |
| Lloyd P. Johnston | Chief Operations Officer | 5. Januar 2023 S | 265.515 | 0 | 0 | $0 |
| Alison D. Schecter | Chief Medical Officer | 2. Januar 2020 A | · | 0 | 0 | $0 |
| Stephen Smolinski | Chief Commercial Officer | 2. Januar 2020 A | 13.812 | 0 | 0 | $0 |
| Elona Kogan Esq. | General Counsel | 2. Januar 2020 A | 182.872 | 0 | 0 | $0 |
| David Abraham | GC, CCO & Corporate Secretary | 15. Juni 2018 A | 5.405 | 0 | 0 | $0 |
| Earl Sands | Chief Medical Officer | 17. November 2017 P | 7.500 | 0 | 0 | $0 |
| Peter Keller | Chief Business Officer | 7. Juli 2017 A | 405 | 0 | 0 | $0 |
| Michael Singer | Direktor | 13. März 2026 G | 49.578 | 0 | 0 | $0 |
| Kemal Malik | Direktor | 2. Januar 2026 A | 11.133 | 0 | 0 | $0 |
| Nishan M Desilva | Direktor | 2. Januar 2026 A | 11.366 | 0 | 0 | $0 |
| Timothy C Barabe | Direktor | 2. Januar 2026 A | 56.966 | 1 | 0 | $205.800 |
| ZENNER PATRICK J | Direktor | 2. Januar 2026 A | 12.974 | 0 | 0 | $0 |
| Timothy A. Springer | Direktor | 2. Januar 2026 A | 8.646.285 | 0 | 0 | $0 |
| Adrian Ion Bot | Direktor | 16. Dezember 2025 A | 5.800 | 0 | 0 | $0 |
| COX CARRIE SMITH | Direktor | 2. Januar 2025 A | 15.629 | 0 | 0 | $0 |
| Aymeric Sallin | Direktor | 2. Januar 2024 A | 178.000 | 0 | 0 | $0 |
| Scott Dunseth Myers | Direktor | 13. November 2023 D | 80.845 | 0 | 0 | $0 |
| ANDO GORAN | Direktor | 2. Januar 2023 A | · | 0 | 0 | $0 |
| Omid Farokhzad | Direktor | 14. Juni 2019 A | 83.333 | 0 | 0 | $0 |
| Amir Nashat | Direktor | 14. Juni 2019 A | 2.676.234 | 0 | 0 | $0 |
| Peter Barton Hutt | Direktor | 15. Juni 2018 A | · | 0 | 0 | $0 |
| Edwin M Kania JR | Direktor | 16. Mai 2017 S | 560.067 | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 27. Juni 2016 C | 1.825.415 | 0 | 0 | $0 |
| Murat Kalayoglu | 10%-Eigentümer | 2. April 2026 M | 5.313.261 | 0 | 0 | $0 |
| RUSNANO | 10%-Eigentümer | 27. Juni 2016 C | 1.476.177 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 13 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| JSML · Janus Detroit Street Trust | 0,42% | 195.163 NS | 31. Juli 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,41% | 12.916 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 43.834 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 10.285 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 332.444 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 6.280 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 17.053 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 169.730 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 376.309 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 74.975 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.441 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 616 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 94.295 SH | 11. September 2026 | Täglich |
RNAC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$38.50
+423,1%
5 35,7%
Starker Kauf
8 57,1%
Kauf
1 7,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-09-28Mittelwert-Ziel $33.67 +357,4%
← Unter allen Zielen
Aktueller Preis $7.36
Tief$16.00
Mittelwert$33.67
Hoch$44.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026